It was great to speak with Dr Qi Cui (Scheie Eye Institute, University of Pennsylvania, PA, USA) about her views on the most promising novel therapies targeting risk factors other than intraocular pressure in glaucoma, and her highlights from AGS21.
Questions
- What are the most promising novel therapies targeting risk factors other than intraocular pressure in glaucoma? (00:17)
- What do you expect to be your highlights of the AGS meeting? (01:28)
Speaker Disclosure: Qi Cui discloses the following: Patent (pending): Penn Center for Innovation; Sponsored Research: Neuraly, Inc., NIH/NEI K08EY029765.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of AGS 2021.
